S. 4987: Pharmaceutical Investment Oversight and Accountability Act

S. 4987 is a federal bill in the 119th Congress. Today, there is no single mandated annual report combining the review of foreign investments in domestic drug manufacturing and DNA technology by the Federal Trade Commission and the Treasury Department. Under this bill, the Federal Trade Commission must… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.